Recce is pleased to provide insights into the Company’s latest Phase II clinical trial dataset, new pre-clinical data, and its ongoing operational activities including a Registrational Phase 3 Clinical Trial in Indonesia.
00:00 Introduction
01:11 Phase II RECCE® 327 Topical Gel
09:27 Clinical Overview & Phase 3 Implications
28:24 Lung Study Data
42:22 Company Update